AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Bajaj Healthcare Board Approves Q3 FY26 Results, Reappoints Key Directors

Bajaj Healthcare Limited

AI Sentiment Analysis

January 19, 2026, 11:23 AM

Bajaj Healthcare's Board approved Q3 FY26 un-audited results. Key directors, including Chairman & MD Mr. Sajankumar Rameshwarlal Bajaj, were re-appointed for three-year terms starting April 1, 2026. The re-appointments are subject to shareholder approval.

Top Queries to Ask About Bajaj Healthcare Limited

Thinking to buy or sell Bajaj Healthcare Limited? Ask AI before you act.

Users

Trusted by 5,000+ users

More Details on This News

Bajaj Healthcare Limited announced the outcome of its Board Meeting held on January 16, 2026. The Board approved the un-audited financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Report from statutory auditors Walker Chandiok & Co. LLP.

Furthermore, the Board approved the re-appointment of key managerial personnel. Mr. Sajankumar Rameshwarlal Bajaj was re-appointed as Chairman & Managing Director for a three-year term from April 1, 2026, to March 31, 2029. Similarly, Mr. Anil Champalal Jain was re-appointed as Managing Director, and Ms. Namrata Sajankumar Bajaj and Mr. Pakshal Anil Jain were re-appointed as Whole-Time Directors for similar terms, all subject to shareholder approval.

The Board Meeting commenced at 4:15 p.m. and concluded at 5:00 p.m. The company also informed about the notice of Postal Ballot pursuant to the Companies Act, 2013.

More News on Bajaj Healthcare Limited

Analyze Bajaj Healthcare Limited

Discover more trending news on Prysm

View All